Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530542 · ClinicalTrials.gov registry record · Phase 1
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01530542 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 35 participants.
The verdict
NCT01530542, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 5-dosing period study to characterize the pharmacokinetics (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body) and the effects of food on the pharmacokinetics of oxycodone. The study will take place over approximately two and a half months and will consist of three phases: a screening visit to determine eligibility for the study, a 5-dosing period treatment phase, and an end-of-study visit.
Interventions
- DRUG oxycodone hydrochloride
- DRUG marketed oxycodone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-07 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01530542
The ClinicalTrials.gov registry entry for NCT01530542 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which oxycodone hydrochloride is the first listed.
NCT01530542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01530542 about?
NCT01530542 is a clinical study titled "A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers". This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 5-dosing period study to characterize the pharmacokinetics (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body) and the effects of food ...
What is the current status of trial NCT01530542?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2010-07. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01530542?
The interventions under investigation include: oxycodone hydrochloride (DRUG), marketed oxycodone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01530542?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.